BioCentury | Jul 23, 2020
Product Development

Encoded to drive first gene therapy into clinic with GV-led $135M series D

...the three approved treatments -- Epidiolex cannabidiol from GW Pharmaceuticals plc (NASDAQ:GWPH); Diacomit stiripentol from Laboratoires Biocodex...
BioCentury | Feb 6, 2020
Finance

Feb. 5 Financial Quick Takes: Aimmune gets $200M Nestlé investment; plus Vineti, MaaT, Kezar, Ziopharm, Ikarovec

...B from new investor SymBiosis LLC and existing investors Seventure Partners, Crédit Mutuel Innovation and Biocodex...
BioCentury | Jun 20, 2019
Company News

Management tracks: Verastem CEO Forrester steps down; plus Recursion, N8 Medical

...Rohman as CEO, effective June 1. Rohman, who was president of North America operations of Laboratoires Biocodex...
BioCentury | Jan 5, 2019
Finance

Ready to launch

The proposed $74 billion takeout of Celgene Corp. by Bristol-Myers Squibb Co. will not shift buysider attention away from upcoming and maturing drug launches heading into 2019, with plenty to track following a record year...
BioCentury | Aug 31, 2018
Clinical News

FDA approves Biocodex's Diacomit for Dravet syndrome seizures

...FDA approved Diacomit stiripentol from Laboratoires Biocodex (Gentilly, France) to treat seizures associated with Dravet syndrome in...
...cytochrome P450 (p450) inhibitor. Laboratoires Biocodex, Gentilly, France Product: Diacomit stiripentol Business: Neurology Jaime De Leon Diacomit, stiripentol (ME2080) Laboratoires Biocodex Cytochrome...
BioCentury | Jul 13, 2018
Financial News

Nextbiotix raises EUR7M series A round to bring IBD therapy into clinic

...led by new investor Auriga Partners. Fellow new investors Sofimac Innovation, Cap Innov'Est, INRA and Biocodex...
BioCentury | Jul 5, 2018
Financial News

Nextbiotix raises €7M series A for microbiome-based therapy

...in a series A round led by Auriga Partners. Sofimac Innovation, Cap Innov'Est, INRA and Biocodex...
...is in preclinical testing for Crohn's disease, ulcerative colitis and irritable bowel syndrome (IBS). Allison Johnson Auriga Partners Biocodex Cap...
BioCentury | May 5, 2016
Emerging Company Profile

Dispatching dysbiosis

...€10 million ($11.5 million) in a series A round from Seventure Partners, CM-CIC Innovation and Laboratoires Biocodex...
...Joël Doré and Mohamad MohtyUniversity collaborators: French National Institute for Agriculture Research (INRA) Corporate partners: Laboratoires Biocodex...
BioCentury | Apr 30, 2015
Distillery Therapeutics

Therapeutics: Lactate dehydrogenase (LDH)

...epilepsy compared with stiripentol. Next steps include synthesis, optimization and testing of additional stiripentol analogs. Laboratoires Biocodex...
BioCentury | Apr 8, 2013
Company News

Apricus Biosciences, Biocodex, Mist Pharmaceuticals sales and marketing update

...North and South American commercialization rights for Totect dexrazoxane to the Biocodex USA subsidiary of Laboratoires Biocodex...
...loss of $31.8 million (see BioCentury, March 25). Apricus Biosciences Inc. (NASDAQ:APRI), San Diego, Calif. Laboratoires Biocodex...
Items per page:
1 - 10 of 13
BioCentury | Jul 23, 2020
Product Development

Encoded to drive first gene therapy into clinic with GV-led $135M series D

...the three approved treatments -- Epidiolex cannabidiol from GW Pharmaceuticals plc (NASDAQ:GWPH); Diacomit stiripentol from Laboratoires Biocodex...
BioCentury | Feb 6, 2020
Finance

Feb. 5 Financial Quick Takes: Aimmune gets $200M Nestlé investment; plus Vineti, MaaT, Kezar, Ziopharm, Ikarovec

...B from new investor SymBiosis LLC and existing investors Seventure Partners, Crédit Mutuel Innovation and Biocodex...
BioCentury | Jun 20, 2019
Company News

Management tracks: Verastem CEO Forrester steps down; plus Recursion, N8 Medical

...Rohman as CEO, effective June 1. Rohman, who was president of North America operations of Laboratoires Biocodex...
BioCentury | Jan 5, 2019
Finance

Ready to launch

The proposed $74 billion takeout of Celgene Corp. by Bristol-Myers Squibb Co. will not shift buysider attention away from upcoming and maturing drug launches heading into 2019, with plenty to track following a record year...
BioCentury | Aug 31, 2018
Clinical News

FDA approves Biocodex's Diacomit for Dravet syndrome seizures

...FDA approved Diacomit stiripentol from Laboratoires Biocodex (Gentilly, France) to treat seizures associated with Dravet syndrome in...
...cytochrome P450 (p450) inhibitor. Laboratoires Biocodex, Gentilly, France Product: Diacomit stiripentol Business: Neurology Jaime De Leon Diacomit, stiripentol (ME2080) Laboratoires Biocodex Cytochrome...
BioCentury | Jul 13, 2018
Financial News

Nextbiotix raises EUR7M series A round to bring IBD therapy into clinic

...led by new investor Auriga Partners. Fellow new investors Sofimac Innovation, Cap Innov'Est, INRA and Biocodex...
BioCentury | Jul 5, 2018
Financial News

Nextbiotix raises €7M series A for microbiome-based therapy

...in a series A round led by Auriga Partners. Sofimac Innovation, Cap Innov'Est, INRA and Biocodex...
...is in preclinical testing for Crohn's disease, ulcerative colitis and irritable bowel syndrome (IBS). Allison Johnson Auriga Partners Biocodex Cap...
BioCentury | May 5, 2016
Emerging Company Profile

Dispatching dysbiosis

...€10 million ($11.5 million) in a series A round from Seventure Partners, CM-CIC Innovation and Laboratoires Biocodex...
...Joël Doré and Mohamad MohtyUniversity collaborators: French National Institute for Agriculture Research (INRA) Corporate partners: Laboratoires Biocodex...
BioCentury | Apr 30, 2015
Distillery Therapeutics

Therapeutics: Lactate dehydrogenase (LDH)

...epilepsy compared with stiripentol. Next steps include synthesis, optimization and testing of additional stiripentol analogs. Laboratoires Biocodex...
BioCentury | Apr 8, 2013
Company News

Apricus Biosciences, Biocodex, Mist Pharmaceuticals sales and marketing update

...North and South American commercialization rights for Totect dexrazoxane to the Biocodex USA subsidiary of Laboratoires Biocodex...
...loss of $31.8 million (see BioCentury, March 25). Apricus Biosciences Inc. (NASDAQ:APRI), San Diego, Calif. Laboratoires Biocodex...
Items per page:
1 - 10 of 13